D68.312
BillableAntiphospholipid antibody with hemorrhagic disorder
HCC Category Mapping
V24HCC 48 — Coagulation Defects and Other Specified Hematological Disorders
0.209ESRDHCC 48 — Coagulation Defects and Other Specified Hematological Disorders
0.000What This Code Means
A bleeding disorder caused by antiphospholipid antibodies that interfere with blood clotting and increase bleeding risk.
Coding Tips
- •Document the presence of antiphospholipid antibodies (lupus anticoagulant, anticardiolipin, or anti-beta-2 glycoprotein) confirmed by testing
- •Distinguish between thrombotic and hemorrhagic presentations; this code is specifically for hemorrhagic manifestations
Clinical Significance
Antiphospholipid antibody with hemorrhagic disorder represents the uncommon scenario where antiphospholipid antibodies cause bleeding rather than the more typical thrombotic presentation. This may occur when antiphospholipid antibodies bind to prothrombin causing hypoprothrombinemia, or when severe thrombocytopenia develops. The hemorrhagic presentation requires different management than typical antiphospholipid syndrome.
Documentation Requirements
- ✓Document positive antiphospholipid antibodies (anticardiolipin, anti-beta2 glycoprotein I, lupus anticoagulant), specific hemorrhagic manifestations, prothrombin levels if hypoprothrombinemia is suspected, and platelet count.
- ✓Record the underlying condition if secondary (systemic lupus erythematosus, other autoimmune disease) and treatment approach.
Excludes 1 — Do NOT code together
Excludes 2 — Not included here, may code separately
Commonly Confused Codes
Code Hierarchy
└D68Other coagulation defects└D68.3Hemorrhagic disorder due to circulating anticoagulants└D68.31Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors└D68.312Antiphospholipid antibody with hemorrhagic disorder
└D68.312Antiphospholipid antibody with hemorrhagic disorder